• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE SG; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE SG; IMPLANTABLE LEAD Back to Search Results
Model Number 0282
Medical Device Problem Codes Signal Artifact/Noise (1036); High impedance (1291)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/26/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If pertinent information is provided in the future, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that this right ventricular (rv) lead exhibited a high out of range gradual rising pacing impedances.It was also noted that there were gradual rising shock impedances within normal limits and noisy signals.Technical services (ts) recommended to have a lead revision.Tachy therapy was stated to be turned off for this patient.This lead remains in service.No adverse patient effects were reported.
 
Additional Manufacturer Narrative
Updated b5.Describe event or problem with additional information obtained from the field.If pertinent information is provided in the future, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that this right ventricular (rv) lead exhibited a high out of range gradual rising pacing impedances.It was also noted that there were gradual rising shock impedances within normal limits and noisy signals.Technical services (ts) recommended to have a lead revision.Tachy therapy was stated to be turned off for this patient.This lead remains in service.No adverse patient effects were reported.Additional information was received from the field.This lead was explanted and replaced.This product has not been returned for analysis.No additional adverse patient effects were reported.
 
Additional Manufacturer Narrative
This product has not been returned to boston scientific and physical analysis could not be conducted.Investigation of the available information/data determined that the observed gradual rise in lvsi measurements was likely associated with calcification, as there was no conclusive evidence of compromised physical or electrical integrity of the lead.This condition may develop over time and can be reflected in a gradual and sustained increase in shock impedance measurements.Boston scientific issued a field safety notice to physicians in july 2025 regarding the potential for reliance defibrillation leads with expanded polytetrafluoroethylene (eptfe) coating to exhibit a pattern of gradually increasing lvsi measurements due to calcification, which may result in elevated high voltage shock impedance (hvsi) measurements and reduced shock efficacy.Review of labeling determined that the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance to labeling.The manual was unlikely to be the cause of the reported complaint; translation, wording, or graphics does not require further review.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of "cause traced to device design".Updated b5.Describe event or problem with additional information obtained from the field.If pertinent information is provided in the future, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that this right ventricular (rv) lead exhibited a high out of range gradual rising pacing impedances.It was also noted that there were gradual rising shock impedances within normal limits and noisy signals.Technical services (ts) recommended to have a lead revision.Tachy therapy was stated to be turned off for this patient.This lead remains in service.No adverse patient effects were reported.Additional information was received from the field.This lead was explanted and replaced.This product has not been returned for analysis.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE SG
Common Device Name
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key23460835
Report Number2124215-2025-79271
Device Sequence Number15698998
Product Code NVY
UDI-Device Identifier00802526431371
UDI-Public(01)00802526431371(17)200919
Combination Product (Y/N)Y
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P910073
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/03/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date09/19/2020
Device Model Number0282
Device Catalogue Number0282
Device Lot Number419956
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/07/2025
Supplement Date Received by Manufacturer12/08/2025
03/02/2026
Initial Report FDA Received Date11/04/2025
Supplement Report FDA Received Date12/26/2025
03/03/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured09/19/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Hospitalization; Required Intervention;
Patient Age30 YR
Patient SexMale
-
-